MedTrace Logo

Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas

NCT00160095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2015-05-07

No results posted yet for this study

Summary

The purpose of this study is to identify in a prospective manner microregional profiles of oxygenation and proliferation based on exogenous and endogenous markers that are predictive for outcome of radiotherapy in squamous cell carcinoma of the larynx and to investigate if these profiles can identify patients that are most likely to benefit from hypoxia modifying treatment strategies like ARCON (Accelerated radiotherapy combined with carbogen breathing and nicotinamide).

Conditions

  • Larynx Cancer

Sponsors & Collaborators

  • Dutch Cancer Society

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Johannes HA Kaanders, M.D., Ph.D. · Radboud University Nijmegen Medical Centre, Dept Radiation Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-07-31
Primary Completion
2010-03-31
Completion
2013-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00160095 on ClinicalTrials.gov